Stockscreener 앱 받기
19.23
0.44%
-0.085
시간 외 거래:
19.28
0.055
+0.29%
전일 마감가:
$19.31
열려 있는:
$19.19
하루 거래량:
15.31M
Relative Volume:
0.79
시가총액:
$36.91B
수익:
$15.29B
순이익/손실:
$1.62B
주가수익비율:
22.80
EPS:
0.8433
순현금흐름:
$1.82B
1주 성능:
-0.29%
1개월 성능:
+0.60%
6개월 성능:
+10.49%
1년 성능:
-10.33%
1일 변동 폭
$18.95
$19.34
1주일 범위
$18.95
$20.05
52주 변동 폭
$14.02
$22.29
Kenvue Inc Stock (KVUE) Company Profile
명칭
Kenvue Inc
전화
908-874-1200
주소
1 KENVUE WAY, SUMMIT
Compare KVUE vs PG, UL, CL, CCL
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
KVUE
Kenvue Inc
|
19.23 | 37.40B | 15.29B | 1.62B | 1.82B | 0.8433 |
PG
Procter Gamble Co
|
144.50 | 346.10B | 86.72B | 16.69B | 15.03B | 6.8375 |
UL
Unilever Plc Adr
|
63.43 | 132.14B | 56.67B | 6.96B | 7.39B | 3.1265 |
CL
Colgate Palmolive Co
|
91.30 | 73.60B | 20.80B | 2.22B | 3.77B | 2.5772 |
CCL
Colgate Palmolive Co
|
27.82 | 37.14B | 26.98B | 3.10B | 2.98B | 2.2492 |
Kenvue Inc Stock (KVUE) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2026-01-30 | 다운그레이드 | Jefferies | Buy → Hold |
| 2025-10-29 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2025-09-26 | 업그레이드 | Rothschild & Co Redburn | Neutral → Buy |
| 2025-04-10 | 개시 | Redburn Atlantic | Neutral |
| 2025-03-24 | 개시 | Evercore ISI | In-line |
| 2025-01-06 | 업그레이드 | Piper Sandler | Neutral → Overweight |
| 2024-12-12 | 다운그레이드 | Deutsche Bank | Buy → Hold |
| 2024-09-24 | 개시 | Jefferies | Buy |
| 2024-09-24 | 다운그레이드 | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-05-28 | 재개 | Citigroup | Neutral |
| 2024-04-11 | 개시 | Bernstein | Underperform |
| 2024-04-03 | 개시 | William Blair | Mkt Perform |
| 2024-03-01 | 재개 | Goldman | Neutral |
| 2023-11-17 | 개시 | Piper Sandler | Neutral |
| 2023-09-11 | 업그레이드 | Deutsche Bank | Hold → Buy |
| 2023-09-07 | 개시 | Canaccord Genuity | Buy |
| 2023-09-06 | 개시 | Argus | Hold |
| 2023-08-24 | 업그레이드 | Goldman | Neutral → Buy |
| 2023-07-25 | 개시 | Edward Jones | Buy |
| 2023-06-01 | 개시 | HSBC Securities | Hold |
| 2023-05-30 | 개시 | BofA Securities | Buy |
| 2023-05-30 | 개시 | Citigroup | Neutral |
| 2023-05-30 | 개시 | Deutsche Bank | Hold |
| 2023-05-30 | 개시 | Exane BNP Paribas | Neutral |
| 2023-05-30 | 개시 | Goldman | Neutral |
| 2023-05-30 | 개시 | JP Morgan | Overweight |
| 2023-05-30 | 개시 | RBC Capital Mkts | Outperform |
| 2023-05-30 | 개시 | UBS | Neutral |
모두보기
Kenvue Inc 주식(KVUE)의 최신 뉴스
Maverick Capital Ltd. Buys Shares of 92,009 Kenvue Inc. $KVUE - MarketBeat
Polar Asset Management Partners Inc. Lowers Position in Kenvue Inc. $KVUE - MarketBeat
Lazard Asset Management LLC Trims Stock Position in Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc (KVUE) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Kenvue Inc (KVUE) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Kenvue Inc. stock rises Monday, outperforms market - MarketWatch
Kenvue Inc (KVUE) Balance Sheet - TradingKey
Renaissance Technologies LLC Purchases New Position in Kenvue Inc. $KVUE - MarketBeat
Morningstar Investment Management LLC Trims Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
First Trust Advisors LP Has $49.81 Million Holdings in Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc. $KVUE Shares Acquired by Gabelli Funds LLC - MarketBeat
Kenvue, Inc. Revenue Breakdown – DUS:J4D - TradingView
Healthcare of Ontario Pension Plan Trust Fund Has $62.17 Million Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
Absolute Gestao de Investimentos Ltda. Takes Position in Kenvue Inc. $KVUE - MarketBeat
Kenvue stock holds steady after latest earnings and outlook - AD HOC NEWS
Tylenol With Naproxen FDA Approval Could Be A Game Changer For Kenvue (KVUE) - Yahoo Finance
Kenvue (KVUE) Gets An FDA Lift On Tylenol As Valuation Looks Tight - Yahoo Finance UK
Naproxen-Powered Pain Relief Medications: Kenvue Receives FDA Approval for TYLENOL… - Trend Hunter
Jim Cramer Says Kimberly-Clark’s Acquisition of Kenvue Creates a High-Margin Powerhouse - Yahoo Finance
5,211,114 Shares in Kenvue Inc. $KVUE Acquired by Kryger Capital LLC - MarketBeat
GABELLI & Co INVESTMENT ADVISERS INC. Raises Holdings in Kenvue Inc. $KVUE - MarketBeat
Bank of Nova Scotia Acquires 816,428 Shares of Kenvue Inc. $KVUE - MarketBeat
Kenvue, Inc. Revenue Breakdown – FWB:J4D - TradingView
Kenvue, Inc. (KVUE) Q1 2025 Earnings ReportResults, Call & Slides - TipRanks
US FDA approves over-the-counter Tylenol combination pill for pain relief - Reuters
Kenvue Inc. stock rises Friday, outperforms market - MarketWatch
Kenvue Inc (KVUE) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Kenvue Inc (KVUE) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Kenvue Inc (KVUE) Valuation: PE, PB & Fair Value Analysis - TradingKey
Kenvue Says FDA Has Granted Tylenol Three-Year Exclusivity For New OTC Formulation - TradingView
FDA approves Tylenol® with Naproxen, the first and only over-the-counter fixed-dose combination of acetaminophen (650 mg) and naproxen sodium (220 mg) - Kenvue
Kenvue Inc (KVUE) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Does Illinois Talc Verdict Successor Liability Ruling Change The Bull Case For Kenvue (KVUE)? - simplywall.st
Kenvue Inc (KVUE) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
This "Boring" Dividend King Is Quietly Turning Into a Growth Machine -- and Many Investors Are Missing It - The Motley Fool
Kenvue Inc (KVUE) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
KVUE|Kenvue Inc|Price:19.477|Chg%:+0.197 - TradingKey
Mizuho Markets Americas LLC Trims Stock Holdings in Kenvue Inc. $KVUE - MarketBeat
Listerine Cool Mint by Kenvuemouthwash classic boosts oral care sales - Ad-hoc-news.de
Capula Management Ltd Grows Position in Kenvue Inc. $KVUE - MarketBeat
Caxton Associates LLP Makes New Investment in Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc. stock falls Thursday, still outperforms market - MarketWatch
Kenvue to announce Q2 2026 results on August 6, 2026 - scanx.trade
Press Release: Kenvue to Announce Second Quarter 2026 Results on August 6, 2026 - 富途牛牛
Kenvue to Announce Second Quarter 2026 Results on August 6, 2026 - The Joplin Globe
Levin Capital Strategies L.P. Raises Stake in Kenvue Inc. $KVUE - MarketBeat
Technical Reactions to KVUE Trends in Macro Strategies - Stock Traders Daily
Kenvue Inc. (NYSE:KVUE) Given Average Rating of "Hold" by Analysts - MarketBeat
Kenvue broadens China focus on minor ailment management - China Daily Global Edition
What to expect from Kenvue’s Q2 2026 earnings report - MSN
KBC Group NV Increases Holdings in Kenvue Inc. $KVUE - MarketBeat
Kenvue Inc (KVUE) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.84%
0.18%
자본화:
|
볼륨(24시간):